Beijing May Retain Leverage Over MEDA Deal
Beijing may maintain leverage over the cross-border flow of MEDA core executives despite the deal being considered a done deal. Potential actions include asking executives not to leave the country or to resign from MEDA. This leverage remains a factor in the transaction, according to Bloomberg Radio. Analysts suggest the deal is not dead but could impact Chinese companies more than American ones due to the rapid evolution of AI technology. Competitors are actively attempting to catch up in the sector. The deal's outcome remains uncertain as technology evolves quickly.
Topics
Developing
- 863d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 863d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 863d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 863d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Bloomberg Radio
“I believe that the deal is already a done deal, however, I believe that Beijing may still have a certain leverage over the cross-border flow of Manus' core executives.”
Bloomberg Radio
“think that's maybe the remaining leverage that Beijing has over this deal.”
Bloomberg Radio
“think that's maybe the remaining leverage that Beijing has over this deal. cancel the deal and then I don't believe it's actually dead, that's mental to matter because in the AI competition, the technology is evolving very fast.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade